AEVIS VICTORIA SA (AEVS) AI Stock Analysis

• Market Cap: CHF1.14B
• Dividend Yield: N/A
• Average Volume (3M): 1.93K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.06
• Revenue Growth: 5.64%
• EPS Growth: 92.66%
• Country: CH
• Employees: 4,731
• Sector: Services
• Sector Strength: N/A
• Industry: Medical - Care Facilities
• EPS (TTM): -0.03
• Shares Outstanding: 84,529,460
• 10 Day Avg. Volume: 2,477
• 30 Day Avg. Volume: 1,930
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: CHF13.50
• Price Target Upside: 0.00%
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 48 Neutral
• Price Target: CHF13.50 ▲(0.00% Upside)

AEVIS VICTORIA SA's overall stock score is primarily impacted by its financial performance, which shows revenue growth but is overshadowed by net losses and high leverage. The technical analysis indicates a neutral trend, while the valuation suggests the stock is overvalued due to negative earnings. The lack of earnings call and corporate events data limits additional insights.

AEVIS VICTORIA SA Business Overview & Revenue Model

Company Description

AEVIS VICTORIA SA is a Swiss-based investment firm that primarily operates in the healthcare, lifestyle, and real estate sectors. It invests in companies offering healthcare services, hospitality and lifestyle amenities, and engages in real estate development and management. Through its subsidiaries, AEVIS VICTORIA SA focuses on creating value by enhancing the quality and efficiency of its investments.

How the Company Makes Money

AEVIS VICTORIA SA generates revenue through its diverse investment portfolio. In healthcare, it earns income from operating private hospitals and medical facilities, providing a range of medical services. In the lifestyle segment, the company generates revenue from its luxury hotel operations and associated hospitality services. Additionally, AEVIS VICTORIA SA capitalizes on its real estate investments by developing, managing, and leasing properties. Key revenue streams include patient service fees, hotel accommodations, and rental income from its real estate holdings. Strategic partnerships and acquisitions enhance its market position and contribute to its financial performance.

AEVIS VICTORIA SA Financial Statement Overview

Summary

AEVIS VICTORIA SA shows mixed financial performance with revenue growth and operational efficiencies but is hindered by persistent net losses and high leverage. The negative net profit margin and high debt-to-equity ratio are significant concerns.

Income Statement

AEVIS VICTORIA SA has shown a mixed performance in its income statement. The revenue growth from 2023 to 2024 was approximately 10.5%, indicating a positive trend. However, the company has been facing persistent EBIT losses, impacting its profitability. The gross profit margin for 2024 is robust at 78.2%, but the net profit margin remains negative due to net losses. EBITDA margin improved, suggesting operational efficiencies, but overall profitability remains a concern.

Balance Sheet

The company's balance sheet indicates a high debt-to-equity ratio of approximately 2.02, which suggests significant leverage. The equity ratio stands at 26.5%, reflecting moderate equity financing. Return on equity is negative due to net losses, posing a risk to financial stability. Despite these issues, the company has managed to increase its stockholders' equity over the years, showing resilience.

Cash Flow

AEVIS VICTORIA SA's cash flow statement shows challenges in generating free cash flow, which has remained negative in recent years. However, there was an improvement in operating cash flow in 2024 compared to 2023. The free cash flow to net income ratio is not favorable due to losses, and the operating cash flow to net income ratio highlights the difficulty in translating earnings into cash. The company needs to improve its cash generation to support operations and growth.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.01B	914.36M	1.03B	823.26M	696.57M
Gross Profit	789.90M	170.09M	185.41M	137.56M	112.46M
EBITDA	92.49M	49.06M	128.29M	86.31M	34.48M
Net Income	-2.87M	-39.30M	58.81M	-4.26M	-31.80M
Balance Sheet
Total Assets	2.00B	1.86B	1.79B	1.73B	1.53B
Cash, Cash Equivalents and Short-Term Investments	36.92M	80.71M	75.43M	63.42M	65.56M
Total Debt	1.07B	1.00B	970.03M	841.27M	841.74M
Total Liabilities	1.42B	1.32B	1.28B	1.14B	1.11B
Stockholders Equity	530.85M	491.89M	469.34M	485.92M	361.23M
Cash Flow
Free Cash Flow	-18.80M	-66.06M	40.28M	-24.07M	-283.46M
Operating Cash Flow	46.50M	42.67M	114.30M	33.53M	23.77M
Investing Cash Flow	-62.28M	35.56M	-56.82M	21.63M	-297.14M
Financing Cash Flow	-28.06M	-72.95M	-45.46M	-57.31M	298.71M

AEVIS VICTORIA SA Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 13.50
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:AEVS, the sentiment is Positive. The current price of 13.5 is above the 20-day moving average (MA) of 13.30, above the 50-day MA of 13.35, and below the 200-day MA of 13.53, indicating a neutral trend. The MACD of 0.04 indicates Negative momentum. The RSI at 55.62 is Neutral, neither overbought nor oversold. The STOCH value of 85.86 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CH:AEVS.

AEVIS VICTORIA SA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DKSH	68 Neutral	CHF3.52B	18.02		4.34%	2.66%	2.91%
SKAN	67 Neutral	CHF1.31B	81.03		0.69%	-3.45%	-49.82%
ADEN	65 Neutral	CHF3.92B	14.41		4.37%	-4.68%	-5.79%
COTN	58 Neutral	CHF1.36B	34.99		0.83%	27.24%	122.39%
Sector *	56 Neutral	$13.56B	17.98	10.03%	0.93%	7.13%	-12.93%
AEVS	48 Neutral	CHF1.14B	―		―	5.64%	92.66%
XLS	―	CHF119.97M	3.58		―	―	―

AEVIS VICTORIA SA Corporate Events

AEVIS VICTORIA’s MRH Switzerland Shows Strong Growth and Profitability in H1 2025

MRH Switzerland AG, a subsidiary of AEVIS VICTORIA SA, reported a 3.7% increase in turnover to CHF 103.9 million in the first half of 2025, driven by organic growth. The company’s EBITDAR improved, reflecting strong demand in the premium segment and effective cost management. Key hotels exceeded expectations, highlighting the success of its flagship strategy. The company plans to continue investing in operational excellence to sustain value creation.

The most recent analyst rating on (CH:AEVS) stock is a Hold with a CHF15.00 price target. To see the full list of analyst forecasts on AEVIS VICTORIA SA stock, see the CH:AEVS Stock Forecast page.

AEVIS VICTORIA SA Approves All Proposals at 2024 General Meeting

AEVIS VICTORIA SA held its ordinary general meeting for the financial year 2024, where all proposals were approved, including the financial statements and the appropriation of profits. The meeting also saw the re-election of board members and the approval of the compensation report, indicating stability and continuity in the company’s governance.

The most recent analyst rating on (CH:AEVS) stock is a Hold with a CHF15.00 price target. To see the full list of analyst forecasts on AEVIS VICTORIA SA stock, see the CH:AEVS Stock Forecast page.

AEVIS VICTORIA SA Reports Strong Q1 2025 Revenue Growth

AEVIS VICTORIA SA reported a 17% increase in consolidated revenue for the first quarter of 2025, driven by organic growth and strategic expansions, particularly in its Swiss Medical Network and MRH Switzerland AG divisions. The company’s focus on expanding its outpatient network and integrating new locations has bolstered its market position, while anticipated real estate sales are expected to further support revenue growth throughout the year.

Swiss Medical Network Sees 21.4% Revenue Surge in Q1 2025

Swiss Medical Network, a part of AEVIS VICTORIA SA, reported a 21.4% increase in revenue for the first quarter of 2025, reaching CHF 258.6 million. This growth is attributed to the integration of Spital Zofingen and CentroMedico, with the Bethanien Private Clinic in Zurich showing the strongest growth. The company plans to continue its development strategy and expects over 20% growth for the year, aiming to enhance integrated care regions.

Swiss Medical Network Partners with Mayo Clinic Care Network

Swiss Medical Network, a subsidiary of AEVIS VICTORIA, has partnered with the Mayo Clinic Care Network, becoming the first Western European healthcare institution to join this prestigious group. This collaboration aims to enhance healthcare in Switzerland by leveraging Mayo Clinic’s expertise in patient care, preventive medicine, and research, offering patients improved access to advanced medical knowledge and treatments without leaving the country.